National Cheng Kung University Hospital

Essais liés24clinical trials

VilleTainanlocalisation

PaysTaiwanlocalisation

SourcelocaleCSV/MySQL

Informations

centre

Synchronisé depuis ClinicalTrials.gov — NCT07476287

Ouvrir le site du centre

Essais cliniques associés

Molécule	Indication / population	Phase	NCT	Titre	Statut
Ipatasertib	Cancer	Phase 3	NCT05862285	UmbrellaMAX — A Rollover Study for Participants Previously Enrolled in a Genentech and/or F. Hoffman-La Roche Sponsored Study	RECRUITING
INBRX-106 - Hexavalent OX40 agonist antibody	Cancer	Phase 1/2	NCT04198766	Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)	RECRUITING
Maridebart cafraglutide	Insuffisance cardiaque	Phase 3	NCT07037459	MARITIME-HF — Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity	RECRUITING
Adagrasib	Cancer	Phase 2/3	NCT04613596	Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7	RECRUITING
BMS-986504	Cancer	Phase 2/3	NCT07063745	MountainTAP-29 — A Study to Compare the Combination of Navlimetostat (BMS-986504) With Pembrolizumab and Chemotherapy Versus Placebo Plus Pembrolizumab and Chemotherapy in First-line Metastatic Non-small Cell Lung Cancer Participants With Homozygous MTAP Deletion	RECRUITING
BI 690517	Maladie rénale chronique	Phase 3	NCT06531824	EASi-KIDNEY™ (The Studies of Heart & Kidney Protection With BI 690517 in Combination With Empagliflozin)	ACTIVE_NOT_RECRUITING
Finerenone (Kerendia, BAY94-8862)	Maladie rénale chronique	Phase 3	NCT05196035	FIONA — A Study to Learn More About How Well the Study Treatment Finerenone Works, How Safe it is, How it Moves Into, Through, and Out of the Body, and the Effects it Has on the Body When Taken With an ACE Inhibitor or Angiotensin Receptor Blocker in Children With Chronic Kidney Disease and Proteinuria	ACTIVE_NOT_RECRUITING
Finerenone (Kerendia, BAY94-8862)	Insuffisance cardiaque	Phase 3	NCT07192952	FIORELLO — A Study to Learn More About How Safe Finerenone is, When it is Taken for a Longer Time With Standard Treatment, in Children and Young Adults With Heart Failure and Left Ventricular Systolic Dysfunction	RECRUITING
Finerenone (Kerendia, BAY94-8862)	Insuffisance cardiaque	Phase 3	NCT07188805	FIORE — A Study to Learn More About How Well Finerenone Works, How Safe it is, and How it Moves Into, Through, and Out of the Body Compared to Placebo When Taken With Standard Treatment in Children With Heart Failure and Left Ventricular Systolic Dysfunction	RECRUITING
Coronary and peripheral stents	Maladie coronarienne	À vérifier	NCT04573660	AV-MDR — Abbott Vascular Medical Device Registry	RECRUITING
Iza-bren	Cancer	Phase 2/3	NCT07100080	Study of Izalontamab Brengitecan (BMS-986507) Versus Platinum-Pemetrexed for EGFR-mutated Non-small Cell Lung Cancer After Failure of EGFR TKI Therapy (IZABRIGHT-Lung01)	RECRUITING
PF-08634404	Cancer	Phase 2	NCT07476287	Symbiotic-Lung-14: A Study to Learn About the Study Medicine Called PF08634404 in Combination With Chemotherapy in Adult Participants With Transformed Small Cell Lung Cancer	RECRUITING
Zanidatamab	Cancer	Phase 3	NCT06282575	Efficacy and Safety of Zanidatamab With Standard-of-care Therapy Against Standard-of-care Therapy for Advanced HER2-positive Biliary Tract Cancer	RECRUITING
Sotorasib	Cancer	Phase 3	NCT05920356	A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)	RECRUITING
Self-Management App for Blood Pressure and Well-Being in Postpartum Women With Hypertensive Disorders of Pregnancy	Hypertension	Non applicable	NCT07486375	Self-Management App for Blood Pressure and Well-Being in Postpartum Women With Hypertensive Disorders of Pregnancy	COMPLETED
ACP-204	Alzheimer	Phase 2/3	NCT06159673	ACP-204 in Adults With Alzheimer's Disease Psychosis	RECRUITING
PF-06821497	Cancer	Phase 3	NCT06629779	A Study to Learn How PF-06821497 (Mevrometostat) Works in Men With Metastatic Castration-resistant Prostate Cancer.	RECRUITING
Adagrasib	Cancer	Phase 3	NCT06875310	A Study of Adagrasib Plus Pembrolizumab Plus Chemotherapy vs. Placebo Plus Pembrolizumab Plus Chemotherapy in Participants With Previously Untreated Non-squamous Non-small Cell Lung Cancer With KRAS G12C Mutation (KRYSTAL-4)	RECRUITING
Donanemab	Alzheimer	Phase 2	NCT07589595	A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7)	RECRUITING
Prasinezumab	Parkinson	Phase 3	NCT07174310	PARAISO — A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease	RECRUITING
Pozelimab + Cemdisiran	Myasthénie	Phase 3	NCT05070858	NIMBLE — A Study to Test How Safe Pozelimab and Cemdisiran Combination Therapy and Cemdisiran Alone Are and How Well They Work in Adult Patients With Generalized Myasthenia Gravis	ACTIVE_NOT_RECRUITING
Adefovir Dipivoxil and Lamivudine	Cancer	À vérifier	NCT00455091	A Phase III Study in Post-operative HBV-related Hepatocellular Carcinoma	TERMINATED
Pembrolizumab	Parkinson	Phase 3	NCT03358472	Pembrolizumab Plus Epacadostat, Pembrolizumab Monotherapy, and the EXTREME Regimen in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (KEYNOTE-669/ECHO-304)	COMPLETED
Sacituzumab govitecan-hziy	Cancer	Phase 3	NCT06486441	Study of Sacituzumab Govitecan Versus Treatment of Physician's Choice in Participants With Endometrial Cancer After Platinum-Based Chemotherapy and Immunotherapy (ASCENT-GYN-01/GOG-3104/ENGOT-en26)	ACTIVE_NOT_RECRUITING